Literature DB >> 24787103

The impact of unplanned postprocedure visits in the management of patients with urinary stones.

Charles D Scales1, Christopher S Saigal2, Janet M Hanley3, Andrew W Dick3, Claude M Setodji3, Mark S Litwin4.   

Abstract

BACKGROUND: Unplanned follow-up care is the focus of intense health policy interest, as evidenced by recent financial penalties imposed under the Affordable Care Act. To date, however, unplanned postoperative care remains poorly characterized, particularly for patients with kidney stones. Our objective was to describe the frequency, variation, and financial impact of unplanned, high-acuity, follow-up visits in the treatment of patients with urinary stone disease.
METHODS: We identified privately insured patients undergoing percutaneous nephrostolithotomy, ureteroscopy, or shock-wave lithotripsy for stone disease. The primary outcome was occurrence of an emergency department visit or hospital admission within 30 days of the procedure. Multivariable models estimated the odds of an unplanned visit and the incremental cost of those visits, controlling for important covariates.
RESULTS: We identified 93,523 initial procedures to fragment or remove stones. Overall, 1 in 7 patients had an unplanned postprocedural visit. Unplanned visits were least common after shock-wave lithotripsy (12%) and occurred with similar frequency after ureteroscopy and percutaneous nephrostolithotomy (15%). Procedures at high-volume facilities were substantially less likely to result in an unplanned visit (odds ratio 0.80, 95% confidence interval [95% CI] 0.74-0.87, P < .001). When an unplanned visit occurred, adjusted incremental expenditures per episode were greater after shock-wave lithotripsy ($32,156 [95% CI $30,453-33,859]) than after ureteroscopy ($23,436 [95% CI $22,281-24,590]).
CONCLUSION: Patients not infrequently experience an unplanned, high-acuity visit after low-risk procedures to remove urinary stones, and the cost of these encounters is substantial. Interventions are indicated to identify and reduce preventable unplanned visits.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24787103      PMCID: PMC4586158          DOI: 10.1016/j.surg.2013.12.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  23 in total

Review 1.  Management of ureteral calculi: a cost comparison and decision making analysis.

Authors:  Yair Lotan; Matthew T Gettman; Claus G Roehrborn; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

2.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

Review 3.  2007 guideline for the management of ureteral calculi.

Authors:  Glenn M Preminger; Hans-Göran Tiselius; Dean G Assimos; Peter Alken; Colin Buck; Michele Gallucci; Thomas Knoll; James E Lingeman; Stephen Y Nakada; Margaret Sue Pearle; Kemal Sarica; Christian Türk; J Stuart Wolf
Journal:  J Urol       Date:  2007-12       Impact factor: 7.450

4.  Getting under the hood of the volume-outcome relationship for radical cystectomy.

Authors:  Brent K Hollenbeck; Stephanie Daignault; Rodney L Dunn; Scott Gilbert; Alon Z Weizer; David C Miller
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

5.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

6.  Understanding differences between high and low volume hospitals for radical prostatectomy.

Authors:  Wendy Siu; Stephanie Daignault; David C Miller; Rodney L Dunn; Scott Gilbert; Alon Z Weizer; Zaojun Ye; Brent K Hollenbeck
Journal:  Urol Oncol       Date:  2007-12-21       Impact factor: 3.498

7.  Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

Authors:  Elena Birman-Deych; Amy D Waterman; Yan Yan; David S Nilasena; Martha J Radford; Brian F Gage
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

8.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

9.  Volume, process of care, and operative mortality for cystectomy for bladder cancer.

Authors:  Brent K Hollenbeck; Yongliang Wei; John D Birkmeyer
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

10.  Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States.

Authors:  Chyng-Wen Fwu; Paul W Eggers; Paul L Kimmel; John W Kusek; Ziya Kirkali
Journal:  Kidney Int       Date:  2013-01-02       Impact factor: 10.612

View more
  18 in total

1.  Variation in Spending around Surgical Episodes of Urinary Stone Disease: Findings from Michigan.

Authors:  Juan San Juan; Hechuan Hou; Khurshid R Ghani; James M Dupree; John M Hollingsworth
Journal:  J Urol       Date:  2017-11-24       Impact factor: 7.450

2.  Hospital volume in ureterorenoscopic stone treatment: 99 operations per year could increase the chance of a better outcome-results of the German prospective multicentre BUSTER project.

Authors:  Steffen Lebentrau; Thomas Enzmann; Mike Lehsnau; Frank Christoph; Martin Schostak; Matthias May
Journal:  World J Urol       Date:  2018-08-09       Impact factor: 4.226

3.  Increased urinary bladder volume improves the detectability of urinary stones at the ureterovesical junction in non-enhanced computed tomography (NECT).

Authors:  Maxim Avanesov; Julja Togmat; Mehtap Solmaz; Michael Gerhard Kaul; Azien Laqmani; Helena Guerreiro; Sarah Keller; Lars Weisbach; Gerhard Adam; Jin Yamamura
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

4.  Which factors affect the hospital re-admission and re-hospitalization after flexible ureterorenoscopy for kidney stone?

Authors:  Ibrahim Buldu; Abdulkadir Tepeler; Tuna Karatag; Ekrem Ozyuvali; Fatih Elbir; Mustafa Yordam; Ali Unsal
Journal:  World J Urol       Date:  2015-12-22       Impact factor: 4.226

Review 5.  Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health.

Authors:  Charles D Scales; Gregory E Tasian; Andrew L Schwaderer; David S Goldfarb; Robert A Star; Ziya Kirkali
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 8.237

6.  Hospital admission for treatment of complications after extracorporeal shock wave lithotripsy for renal stones: a study of risk factors.

Authors:  Ahmed R El-Nahas; Diaa-Eldin Taha; Mohamed M Elsaadany; Mohamed H Zahran; Mohamed Hassan; Khaled Z Sheir
Journal:  Urolithiasis       Date:  2017-05-29       Impact factor: 3.436

7.  Analysis of factors affecting re-admission after retrograde intrarenal surgery for renal stone.

Authors:  Tae Jin Kim; In Jae Lee; Jung Keun Lee; Hak Min Lee; Chang Wook Jeong; Sung Kyu Hong; Seok-Soo Byun; Jong Jin Oh
Journal:  World J Urol       Date:  2018-10-03       Impact factor: 4.226

8.  Preoperative Belladonna and Opium Suppository for Ureteral Stent Pain: A Randomized, Double-blinded, Placebo-controlled Study.

Authors:  Franklin C Lee; Sarah K Holt; Ryan S Hsi; Brandon M Haynes; Jonathan D Harper
Journal:  Urology       Date:  2016-09-19       Impact factor: 2.649

9.  Factors affecting hospital readmission and rehospitalization following percutaneous nephrolithotomy.

Authors:  Abdulkadir Tepeler; Tuna Karatag; Adem Tok; Ekrem Ozyuvali; Ibrahim Buldu; Sina Kardas; Okkes Taha Kucukdagli; Ali Unsal
Journal:  World J Urol       Date:  2015-07-30       Impact factor: 4.226

10.  Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?

Authors:  John Michael DiBianco; T W Jarrett; Patrick Mufarrij
Journal:  Rev Urol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.